NEW YORK, Nov. 10, 2016 /PRNewswire/ -- EU5 Multiparameter Patient Monitoring Market Outlook to 2022 SummaryGlobalData's new report, "EU5 Multiparameter Patient Monitoring Market Outlook to 2022", provides key market data on the EU5 Multiparameter Patient Monitoring market. The report provides value, in millions of US dollars, volume (in units) and average price data (in US dollars), within market segments - High Acuity Monitors, Mid Acuity Monitors, Low Acuity Monitors and Multiparameter Central Stations. The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is available in the report.The data in the report is derived from dynamic market forecast models. GlobalData uses epidemiology and capital equipment-based models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible.The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers.Capital equipment-based forecasting models are done based on the installed base, replacements and new sales of a specific device/equipment in healthcare facilities such as hospitals, clinics and diagnostic centers. Data for average number of units per facility is used to arrive at the installed base of the capital equipment. Sales for a particular year are arrived at by calculating the replacement units and new units (additional and first-time purchases).Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.